{"id":"W2937112267","doi":"10.1093/rheumatology/kez107.079","title":"263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period","year":2019,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Immunogenicity; Ankylosing spondylitis; Monoclonal antibody; Immunology; Spondylitis; Monoclonal; Dermatology; Arthritis; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002051736,0.0002042253,0.0006392109,0.0001796554,0.0001650508,0.0005426045,0.0001781192,0.0003259578,0.001747356],"category_scores_gemma":[0.001698123,0.0001972732,0.0004505365,0.0003632237,0.000202578,0.0002658146,0.0001506339,0.0003260221,0.000341839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002638044,"about_ca_system_score_gemma":0.0002484247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004201939,"about_ca_topic_score_gemma":0.0009191954,"domain_scores_codex":[0.9990124,0.0004831596,0.0001260918,0.0001048935,0.0002059374,0.00006756663],"domain_scores_gemma":[0.998948,0.0002834324,0.0004671995,0.0000719426,0.000145572,0.00008390359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06737331,0.00198006,0.6197073,0.002411793,0.001822306,0.0008601526,0.0004030746,0.0008356574,0.04573295,0.0001486595,0.003254617,0.2554701],"study_design_scores_gemma":[0.003337402,0.06722914,0.9066924,0.0002238043,0.001025477,0.002522012,0.0002670101,0.001132274,0.008830334,0.00006684114,0.008646427,0.00002685873],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888119,0.009269169,0.0001832959,0.0000909377,0.00002717674,0.00006056868,0.0002057832,0.00001635916,0.001334832],"genre_scores_gemma":[0.9984683,0.0008111731,0.0001122836,0.00005631981,0.00001898666,0.00003142509,0.0001817249,0.000001514949,0.0003181746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002051736,"threshold_uncertainty_score":0.01085079,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005673772900500633,"score_gpt":0.2108799142451956,"score_spread":0.205206141344695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}